{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:45:46Z","timestamp":1792431946066,"version":"4.5.0"},"reference-count":117,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.jceh.2021.11.004","type":"journal-article","created":{"date-parts":[[2021,11,14]],"date-time":"2021-11-14T00:14:22Z","timestamp":1636848862000},"page":"948-964","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"title":["Value of Liver Function Tests in Cirrhosis"],"prefix":"10.1016","volume":"12","author":[{"given":"Praveen","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2021.11.004_bib1","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jhep.2018.05.011","article-title":"Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies","volume":"69","author":"Pimpin","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.11.004_bib2","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1159\/000456580","article-title":"Lessons from epidemiology: the burden of liver disease","volume":"35","author":"Rowe","year":"2017","journal-title":"Dig Dis"},{"key":"10.1016\/j.jceh.2021.11.004_bib3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1365-2893.2003.00487.x","article-title":"Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures","volume":"11","author":"Lavanchy","year":"2004","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.jceh.2021.11.004_bib4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJM199701303360507","article-title":"The treatment of chronic viral hepatitis","volume":"336","author":"Hoofnagle","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2021.11.004_bib5","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0140-6736(14)61838-9","article-title":"Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis","volume":"384","author":"Williams","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jceh.2021.11.004_bib6","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s11894-012-0308-y","article-title":"Natural history of cirrhosis","volume":"15","author":"Asrani","year":"2013","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.jceh.2021.11.004_bib7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D'Amico","year":"2006","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.11.004_bib8","doi-asserted-by":"crossref","first-page":"R1147","DOI":"10.1016\/j.cub.2017.09.019","article-title":"The liver","volume":"27","author":"Trefts","year":"2017","journal-title":"Curr Biol"},{"key":"10.1016\/j.jceh.2021.11.004_bib9","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3748\/wjg.v20.i2.475","article-title":"Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"20","author":"Sumida","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2021.11.004_bib10","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMra1610570","article-title":"Use of liver imaging and biopsy in clinical practice","volume":"377","author":"Tapper","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2021.11.004_bib11","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/bmj.38050.593634.63","article-title":"Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study","volume":"328","author":"Kim","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.jceh.2021.11.004_bib12","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2147\/CEG.S160537","article-title":"Liver function tests in identifying patients with liver disease","volume":"11","author":"Ahmed","year":"2018","journal-title":"Clin Exp Gastroenterol"},{"key":"10.1016\/j.jceh.2021.11.004_bib13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/cld.554","article-title":"The holy grail of a biomarker for \"liver function\"","volume":"7","author":"Majumdar","year":"2016","journal-title":"Clin Liver Dis (Hoboken)."},{"key":"10.1016\/j.jceh.2021.11.004_bib14","first-page":"207","article-title":"Assessing liver function","volume":"13","author":"Sakka","year":"2007","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.jceh.2021.11.004_bib15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1136\/postgradmedj-2015-133715","article-title":"Evaluation of abnormal liver function tests","volume":"92","author":"Agrawal","year":"2016","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jceh.2021.11.004_bib16","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2017-314924","article-title":"Guidelines on the management of abnormal liver blood tests","volume":"67","author":"Newsome","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2021.11.004_bib17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s12072-019-09946-3","article-title":"Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update","volume":"13","author":"Sarin","year":"2019","journal-title":"Hepatol Int"},{"issue":"1 suppl l","key":"10.1016\/j.jceh.2021.11.004_bib18","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1016\/j.jhep.2014.11.045","article-title":"Acute-on-chronic liver failure: a new syndrome that will re-classify cirrhosis","volume":"62","author":"Arroyo","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.11.004_bib19","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S1665-2681(19)30910-X","article-title":"Bilirubin alone as a biomarker for short-term mortality in acute-on-chronic liver failure: an important prognostic indicator","volume":"13","author":"L\u00f3pez-Vel\u00e1zquez","year":"2013","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jceh.2021.11.004_bib20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/gut.20.2.137","article-title":"Serum bilirubin: a prognostic factor in primary biliary cirrhosis","volume":"20","author":"Shapiro","year":"1979","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2021.11.004_bib21","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/lt.21040","article-title":"Do we need to MEND the MELD?","volume":"13","author":"Gish","year":"2007","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2021.11.004_bib22","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.hep.2003.09.038","article-title":"Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone","volume":"38","author":"Mathurin","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.11.004_bib23","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/MCG.0b013e31818980ac","article-title":"Predictive value of aspartate aminotransferase to alanine aminotransferase ratio for hepatic fibrosis and clinical adverse outcomes in patients with primary biliary cirrhosis","volume":"43","author":"Su","year":"2009","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.jceh.2021.11.004_bib24","first-page":"709","article-title":"Mildly elevated liver transaminase levels: causes and evaluation","volume":"96","author":"Oh","year":"2017","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.jceh.2021.11.004_bib25","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jhep.2007.07.022","article-title":"The clinical significance of persistently normal ALT in chronic hepatitis B infection","volume":"47","author":"Lai","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.11.004_bib26","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3350\/cmh.2020.0189","article-title":"Recent updates on the management of autoimmune hepatitis","volume":"27","author":"Komori","year":"2021","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jceh.2021.11.004_bib27","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.11.004_bib28","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0016-5085(88)80022-2","article-title":"Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis","volume":"95","author":"Williams","year":"1988","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.jceh.2021.11.004_bib29","first-page":"1486","article-title":"Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: a meta-analysis Hepatology","volume":"66","author":"Xiao","year":"2017"},{"key":"10.1016\/j.jceh.2021.11.004_bib30","first-page":"4806","article-title":"Predictors of esophageal varices and first variceal bleeding in liver cirrhosis patients World","volume":"23","author":"Kraja","year":"2017","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.jceh.2021.11.004_bib31","first-page":"865","article-title":"Liver stiffness measurement, better than APRI, Fibroindex, Fib-4, and NBI gastroscopy, predicts portal hypertension in patients with cirrhosis Cell","volume":"71","author":"Zhang","year":"2015","journal-title":"Biochem Biophys"},{"issue":"1","key":"10.1016\/j.jceh.2021.11.004_bib32","first-page":"292","article-title":"Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: a systemic review and meta-analysis Hepatology","volume":"61","author":"Xiao","year":"2015"},{"key":"10.1016\/j.jceh.2021.11.004_bib33","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001795","article-title":"Diagnostic accuracy of APRI, AAR, FIB-4, FI, king, Lok, Forns, and FibroIndex scores in predicting the presence of esophageal varices in liver cirrhosis: a systematic review and meta-analysis","volume":"94","author":"Deng","year":"2015","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.jceh.2021.11.004_bib34","doi-asserted-by":"crossref","first-page":"100248","DOI":"10.1016\/j.jhepr.2021.100248","article-title":"Real-world experience with obeticholic acid in patients with primary biliary cholangitis","volume":"3","author":"D'Amato","year":"2021","journal-title":"JHEP Rep"},{"issue":"4","key":"10.1016\/j.jceh.2021.11.004_bib35","first-page":"743","article-title":"Rule of changes in serum GGT levels and GGT\/ALT and AST\/ALT ratios in primary hepatic carcinoma patients with different AFP levels Cancer Biomark","volume":"21","author":"Yang","year":"2018"},{"key":"10.1016\/j.jceh.2021.11.004_bib36","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1186\/s12885-019-6011-8","article-title":"The prognostic significance of serum gamma-glutamyltransferase levels and AST\/ALT in primary hepatic carcinoma","volume":"19","author":"Zhang","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jceh.2021.11.004_bib37","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.26338","article-title":"Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications","volume":"58","author":"Garcia-Martinez","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.11.004_bib38","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/hep.31558","article-title":"Risk prediction models for post-operative mortality in patients with cirrhosis","volume":"73","author":"Mahmud","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.11.004_bib39","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/S0140-6736(18)30840-7","article-title":"Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial","volume":"391","author":"Caraceni","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jceh.2021.11.004_bib40","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12876-020-01337-5","article-title":"The impact of albumin infusion on the risk of rebleeding and in-hospital mortality in cirrhotic patients admitted for acute gastrointestinal bleeding: a retrospective study of a single institute","volume":"20","author":"Wang","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jceh.2021.11.004_bib41","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/ijlh.12934","article-title":"Are prothrombin time and clot waveform analysis useful in detecting a bleeding risk in liver cirrhosis?","volume":"41","author":"Ruberto","year":"2019","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jceh.2021.11.004_bib42","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0973-6883(11)60233-8","article-title":"Predicting mortality across a broad spectrum of liver disease-an assessment of model for end-stage liver disease (MELD), Child-Turcotte-pugh (CTP), and creatinine-modified CTP scores","volume":"1","author":"Chawla","year":"2011","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2021.11.004_bib43","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1002\/hep.30103","article-title":"Coagulation failure in patients with acute-on-chronic liver failure (ACLF) and decompensated cirrhosis: beyond INR","volume":"68","author":"Blasi","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.11.004_bib44","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jcrc.2017.07.053","article-title":"Balanced haemostasis with both hypo- and hyper-coagulable features in critically ill patients\u00a0with acute-on-chronic-liver failure","volume":"43","author":"Fisher","year":"2018","journal-title":"J\u00a0Crit Care"},{"key":"10.1016\/j.jceh.2021.11.004_bib45","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/gutjnl-2015-309922","article-title":"Management of acute-onchronic liver failure: rotational thromboelastometry may reduce substitution of coagulation factors in liver cirrhosis","volume":"65","author":"Bedreli","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2021.11.004_bib46","first-page":"1491","article-title":"Faculty of the 7th international coagulation in liver disease. Concepts and controversies in haemostasis and thrombosis associated with liver disease: proceedings of the 7th international coagulation in liver disease conference","volume":"118","author":"Intagliata","year":"2018","journal-title":"Thromb Haemostasis"},{"key":"10.1016\/j.jceh.2021.11.004_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193824","article-title":"Share Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans","volume":"13","author":"Luo","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2021.11.004_bib48","article-title":"Total bile acid-to-cholesterol ratio as a novel noninvasive marker for significant liver fibrosis and cirrhosis in patients with non-cholestatic chronic hepatitis","volume":"99","author":"Yan","year":"2020","journal-title":"B\u00a0Virus Infect Medi (Baltimore)"},{"key":"10.1016\/j.jceh.2021.11.004_bib49","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/hep.21941","article-title":"Platelet count is not a predictor of the presence or development of gastroesophageal varices in cirrhosis","volume":"47","author":"Qamar","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.11.004_bib50","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/ajg.2017.457","article-title":"Platelet count does not predict bleeding in cirrhotic patients: results from the pro-liver study","volume":"113","author":"Basili","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2021.11.004_bib51","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1478-3231.2010.02260.x","article-title":"Prospective validation of P2\/MS noninvasive index using complete blood counts for detecting oesophageal varices in B-viral cirrhosis","volume":"30","author":"Kim","year":"2010","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2021.11.004_bib52","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Baveno VI Faculty.Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension","volume":"63","author":"de Franchis","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.11.004_bib53","first-page":"7895","article-title":"Thrombocytopenia for prediction of hepatocellular carcinoma recurrence: systematic review and meta-analysis World","volume":"21","author":"Pang","year":"2015","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.jceh.2021.11.004_bib54","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1002\/cncr.22242","article-title":"Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma","volume":"107","author":"Lu","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.jceh.2021.11.004_bib55","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.cgh.2010.03.025","article-title":"Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial","volume":"8","author":"Seeff","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2021.11.004_bib56","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2036.1995.tb00380.x","article-title":"Review article: quantitative tests of liver function","volume":"9","author":"Jalan","year":"1995","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2021.11.004_bib57","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/SLA.0b013e31825d5d47","article-title":"Physiological and biochemical basis of clinical liver function tests: a review","volume":"257","author":"Hoekstra","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.jceh.2021.11.004_bib58","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/hep.24752","article-title":"Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: results from the Hepatitis C Antiviral Long-term Treatment against Cirrhosis Trial","volume":"55","author":"Everson","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.11.004_bib59","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00228-008-0553-z","article-title":"Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction","volume":"64","author":"Verbeeck","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jceh.2021.11.004_bib60","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ejphar.2007.04.061","article-title":"Antipyrine clearance in comparison to conventional liver function tests in hepatitis C virus patients","volume":"569","author":"Mahmoud","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jceh.2021.11.004_bib61","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/liv.13070","article-title":"Relationship between Indocyanine Green Retention Test, decompensation and survival in patients with Child -Pugh A cirrhosis and portal hypertension","volume":"36","author":"Lisotti","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2021.11.004_bib62","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/hep.1840200218","article-title":"Monoethylglicinexylidide test: a prognostic indicator of survival in cirrhosis","volume":"20","author":"Arrigoni","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.11.004_bib63","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s10620-018-5360-5","article-title":"Prospective assessment of liver function by an enzymatic liver function test to estimate short-term survival in patients with liver cirrhosis","volume":"64","author":"Jara","year":"2019","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2021.11.004_bib64","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2036.2007.03389.x","article-title":"Portal-systemic shunting in patients with fibrosis or cirrhosis due to chronic hepatitis C: the minimal model for measuring cholate clearances and shunt","volume":"26","author":"Everson","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2021.11.004_bib65","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.trsl.2020.12.010","article-title":"The within-individual reproducibility of the disease severity index from the HepQuant SHUNT test of liver function and physiology","volume":"233","author":"Burton","year":"2021","journal-title":"Transl Res"},{"key":"10.1016\/j.jceh.2021.11.004_bib66","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/apt.16283","article-title":"Predicting clinical decompensation in patients with cirrhosis using the Hepquant-SHUNT test","volume":"53","author":"Fallahzadeh","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2021.11.004_bib67","article-title":"Fluid biomarkers for predicting the prognosis of liver cirrhosis","volume":"20","author":"Chen","year":"2020","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.jceh.2021.11.004_bib68","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/joim.12054","article-title":"Soluble urokinase plasminogen activator receptor is compartmentally regulated in decompensated cirrhosis and indicates immune activation and short-term mortality","volume":"2741","author":"Zimmermann","year":"2013","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jceh.2021.11.004_bib69","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/hep.1840400409","article-title":"Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death","volume":"40","author":"Heuman","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.11.004_bib70","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa0801209","article-title":"Hyponatremia and mortality among patients on the liver-transplant waiting list","volume":"359","author":"Kim","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2021.11.004_bib71","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jhep.2016.03.002","article-title":"Neutrophil gelatinaseassociated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis","volume":"65","author":"Ariza","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.11.004_bib72","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/j.1478-3231.2012.02766.x","article-title":"Cystatin C is a strong predictor of survival in patients with cirrhosis: is a cystatin C-based MELD better?","volume":"32","author":"Finkenstedt","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2021.11.004_bib73","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jhep.2010.07.047","article-title":"Transporters involved in the hepatic uptake of (99m)tc-mebrofenin and indocyanine green","volume":"54","author":"de Graaf","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.11.004_bib74","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2967\/jnumed.109.069724","article-title":"99m)tc-mebrofenin hepatobiliary scintigraphy with SPECT for the assessment of hepatic function and liver functional volume before partial hepatectomy","volume":"51","author":"de Graaf","year":"2010","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jceh.2021.11.004_bib75","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.hpb.2017.05.007","article-title":"99mTc-mebrofenin hepatobiliary scintigraphy predicts liver failure following major liver resection for perihilar cholangiocarcinoma","volume":"19","author":"Olthof","year":"2017","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.jceh.2021.11.004_bib76","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1159\/000343092","article-title":"Assessment of hepatic function with gd-eob-dtpa-enhanced hepatic MRI","volume":"30","author":"Bae","year":"2012","journal-title":"Dig Dis"},{"key":"10.1016\/j.jceh.2021.11.004_bib77","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF02990020","article-title":"Clinical assessment of hepatic functional reserve using 99mTc DTPA galactosyl human serum albumin SPECT to prognosticate chronic hepatic diseases--validation of the use of SPECT and a new indicator","volume":"17","author":"Onodera","year":"2003","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.jceh.2021.11.004_bib78","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2214\/AJR.17.18411","article-title":"Predictability of 99mTc-galactosyl human serum albumin scintigraphy for posthepatectomy liver failure","volume":"210","author":"Kato","year":"2018","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jceh.2021.11.004_bib79","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3350\/cmh.2014.20.1.6","article-title":"Hepatic venous pressure gradient: clinical use in chronic liver disease","volume":"20","author":"Suk","year":"2014","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jceh.2021.11.004_bib80","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jhep.2009.01.014","article-title":"Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis","volume":"50","author":"Ripoll","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.11.004_bib81","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrgastro.2009.149","article-title":"The clinical use of HVPG measurements in chronic liver disease","volume":"6","author":"Bosch","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2021.11.004_bib82","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.dld.2011.03.002","article-title":"Hepatic venous pressure gradient measurement in clinical hepatology","volume":"43","author":"Merkel","year":"2011","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jceh.2021.11.004_bib83","first-page":"745","article-title":"Prediction of esophageal varices and variceal hemorrhage in patients with acute upper gastrointestinal bleeding","volume":"64","author":"Rockey","year":"2016","journal-title":"J\u00a0Invest Med"},{"key":"10.1016\/j.jceh.2021.11.004_bib84","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/j.1365-2036.2008.03701.x","article-title":"Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease","volume":"27","author":"Bureau","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2021.11.004_bib85","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1053\/j.gastro.2012.05.035","article-title":"Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis","volume":"143","author":"Colecchia","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2021.11.004_bib86","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.3748\/wjg.v22.i12.3441","article-title":"Osteopontin: a non-invasive parameter of portal hypertension and prognostic marker of cirrhosis","volume":"22","author":"Bruha","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2021.11.004_bib87","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/hep.25806","article-title":"von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis","volume":"56","author":"Ferlitsch","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.11.004_bib88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149230","article-title":"The VITRO score (von Willebrand factor Antigen\/thrombocyte ratio) as a new marker for clinically significant portal hypertension in comparison to other non-invasive parameters of fibrosis including ELF test","volume":"11","author":"Hametner","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2021.11.004_bib89","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002877","article-title":"Child-pugh versus MELD score for the assessment of prognosis in liver cirrhosis: a systematic review and meta-analysis of observational studies","volume":"95","author":"Peng","year":"2016","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.jceh.2021.11.004_bib90","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1365-2036.2005.02691.x","article-title":"Systematic review: the model for end-stage liver disease \u2013 should it replace Child\u2013Pugh\u2019s classification for assessing prognosis in cirrhosis?","volume":"22","author":"Cholongitas","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2021.11.004_bib91","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1053\/j.gastro.2006.02.010","article-title":"Evidence-based incorporation of serum sodium concentration into MELD","volume":"130","author":"Biggins","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2021.11.004_bib92","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/lt.500030613","article-title":"Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases","volume":"3","author":"Lucey","year":"1997","journal-title":"Liver Transplant Surg"},{"key":"10.1016\/j.jceh.2021.11.004_bib93","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/hep.26972","article-title":"Evaluation for liver transplantation in adults: 2013 practice guideline by the American association for the study of liver diseases and the American society of transplantation","volume":"59","author":"Martin","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.11.004_bib94","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.21607","article-title":"The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids","volume":"45","author":"Louvet","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.11.004_bib95","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1053\/jlts.2000.6503","article-title":"Adaptation of the Mayo primary Biliary cirrhosis natural history model for application in liver transplant candidates","volume":"6","author":"Kim","year":"2000","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2021.11.004_bib96","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0025-6196(11)64614-4","article-title":"A\u00a0revised natural history model for primary sclerosing cholangitis","volume":"75","author":"Kim","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jceh.2021.11.004_bib97","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.jhep.2015.07.021","article-title":"Use of the methacetin breath test to classify the risk of cirrhotic complications and mortality in patients evaluated\/listed for liver transplantation","volume":"63","author":"Stravitz","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.11.004_bib98","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/gut.2005.069153","article-title":"Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study","volume":"55","author":"Foucher","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2021.11.004_bib99","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000335430","article-title":"Risk assessment of development of hepatic decompensation in histologically proven hepatitis B viral cirrhosis using liver stiffness measurement","volume":"85","author":"Kim","year":"2012","journal-title":"Digestion"},{"key":"10.1016\/j.jceh.2021.11.004_bib100","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/hep.22870","article-title":"Prospective risk assessment for Hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography","volume":"49","author":"Masuzaki","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.11.004_bib101","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.cgh.2013.07.034","article-title":"Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis","volume":"11","author":"Singh","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2021.11.004_bib102","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2007.05.024","article-title":"Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis","volume":"133","author":"Ripoll","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2021.11.004_bib103","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/hep.20871","article-title":"Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD Era","volume":"42","author":"Ripoll","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.11.004_bib104","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/MCG.0b013e31825f2622","article-title":"Comparison of hepatic venous pressure gradient and two models of end-stage liver disease for predicting the survival in patients with decompensated liver cirrhosis","volume":"46","author":"Suk","year":"2012","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.jceh.2021.11.004_bib105","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/01.sla.0000171327.29262.e0","article-title":"Model for End- Stage Liver Disease (MELD) predicts nontransplant surgical mortality in patients with cirrhosis","volume":"242","author":"Northup","year":"2005","journal-title":"Ann Surg"},{"key":"10.1016\/j.jceh.2021.11.004_bib106","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S0016-5085(96)70070-7","article-title":"Surgical resection of Hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure","volume":"111","author":"Bruix","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2021.11.004_bib107","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jhep.2011.06.027","article-title":"Assessment of portal hypertension by transient elastography in patients with compensated cirrhosis and potentially resectable liver tumors","volume":"56","author":"Llop","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.11.004_bib108","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1006\/jsre.2001.6328","article-title":"ICG pulse spectrophotometry for perioperative liver function in hepatectomy","volume":"103","author":"Okuchi","year":"2002","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.jceh.2021.11.004_bib109","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00534-004-0965-9","article-title":"Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test","volume":"12","author":"Imamura","year":"2005","journal-title":"J\u00a0Hepatobil Pancreat Surg"},{"key":"10.1016\/j.jceh.2021.11.004_bib110","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1499-3872(14)60267-8","article-title":"Advances in preoperative assessment of liver function","volume":"13","author":"Ge","year":"2014","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.jceh.2021.11.004_bib111","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2967\/jnumed.110.078360","article-title":"Quantitative assessment of hepatic function during liver regeneration in a standardized rat model","volume":"52","author":"de Graaf","year":"2011","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jceh.2021.11.004_bib112","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/lt.24373","article-title":"Serial changes of cytokines and growth factors in peripheral circulation after right lobe donor hepatectomy","volume":"22","author":"Sasturkar","year":"2016","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2021.11.004_bib113","doi-asserted-by":"crossref","first-page":"20877","DOI":"10.3390\/ijms141020877","article-title":"Serial changes of serum growth factor levels and liver regeneration after partial hepatectomy in healthy humans","volume":"14","author":"Matsumoto","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jceh.2021.11.004_bib114","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000488078","article-title":"Serial assessment of growth factors associated with liver regeneration in patients operated with associating liver partition and portal vein ligation for staged hepatectomy","volume":"59","author":"Sparrelid","year":"2018","journal-title":"Eur Surg Res"},{"key":"10.1016\/j.jceh.2021.11.004_bib115","first-page":"31","article-title":"Markers of liver regeneration-the role of growth factors and cytokines: a systematic","volume":"20","author":"Hoffmann","year":"2020","journal-title":"reviewBMC Surg"},{"key":"10.1016\/j.jceh.2021.11.004_bib116","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1002\/hep.30572","article-title":"Predicting postoperative liver dysfunction based on blood-derived MicroRNA signatures","volume":"69","author":"Starlinger","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.11.004_bib117","doi-asserted-by":"crossref","first-page":"13739","DOI":"10.1038\/s41598-021-92888-4","article-title":"Influence of cytokines, circulating markers and growth factors on liver regeneration and post-hepatectomy liver failure: a systematic review and meta-analysis","volume":"2","author":"Murtha-Lemekhova","year":"2021","journal-title":"Sci Rep"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688321005685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688321005685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:08:30Z","timestamp":1760854110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688321005685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":117,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0973688321005685"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2021.11.004","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Value of Liver Function Tests in Cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2021.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}